Sedana Medical publishes its Annual Report for 2022
Sedana Medical AB (publ) publishes its Annual Report for 2022. The Annual Report describes important events and financial information for 2022, as well as the progress the company has made on its strategic priorities during the year.“In 2022, we took several important steps closer to our vision – to make inhaled sedation a global standard therapy for mechanically ventilated patients in intensive care. The first patient was included in the clinical programme in the United States, NICE in the UK recommended Sedaconda ACD as a cost-saving option and the first bottles of Sedaconda (isoflurane)